These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
222 related articles for article (PubMed ID: 22760446)
1. Fibrinogen Melbourne: a novel congenital hypodysfibrinogenemia caused by γ326Cys-Phe in the fibrinogen γ chain, presenting as massive splanchnic venous thrombosis. Cheah CY; Brennan SO; Kennedy H; Januszewicz EH; Maxwell E; Burbury K Blood Coagul Fibrinolysis; 2012 Sep; 23(6):563-5. PubMed ID: 22760446 [TBL] [Abstract][Full Text] [Related]
2. A novel Asp344Val substitution in the fibrinogen gamma chain (fibrinogen Caen) causes dysfibrinogenemia associated with thrombosis. Robert-Ebadi H; Le Querrec A; de Moerloose P; Gandon-Laloum S; Borel Derlon A; Neerman-Arbez M Blood Coagul Fibrinolysis; 2008 Oct; 19(7):697-9. PubMed ID: 18832913 [TBL] [Abstract][Full Text] [Related]
3. Congenital Hypodysfibrinogenemia due to γ326Cys→Tyr Mutation: Third Ever-Described Case Associated with Recurrent Venous Thrombosis and COVID Vaccine. Nanthan KR; Pedersen IS; Andersen DT; Bor MV Acta Haematol; 2024; 147(5):564-570. PubMed ID: 39140696 [TBL] [Abstract][Full Text] [Related]
4. Fibrinogen Saint-Germain II: hypofibrinogenemia due to heterozygous gamma N345S mutation. de Raucourt E; de Mazancourt P; Maghzal GJ; Brennan SO; Mosesson MW Thromb Haemost; 2005 Nov; 94(5):965-8. PubMed ID: 16363237 [TBL] [Abstract][Full Text] [Related]
5. Hypodysfibrinogenemia: A novel abnormal fibrinogen associated with bleeding and thrombotic complications. Amri Y; Kallel C; Becheur M; Dabboubi R; Elloumi M; Belaaj H; Kammoun S; Messaoud T; de Moerloose P; Toumi Nel H Clin Chim Acta; 2016 Sep; 460():55-62. PubMed ID: 27343352 [TBL] [Abstract][Full Text] [Related]
6. Congenital hypofibrinogenemia associated with novel heterozygous fibrinogen Bbeta and gamma chain mutations. Castaman G; Giacomelli SH; Duga S; Rodeghiero F Haemophilia; 2008 May; 14(3):630-3. PubMed ID: 18393984 [No Abstract] [Full Text] [Related]
7. Fibrinogen Columbus II: A novel c.1075G>T mutation in the FGG gene causing hypodysfibrinogenemia and thrombosis in an adolescent male. Kumar R; Dawson J; Varga E; Canini JT; Monda KL; Dunn AL Pediatr Blood Cancer; 2019 Sep; 66(9):e27832. PubMed ID: 31131962 [TBL] [Abstract][Full Text] [Related]
8. Fibrinogen St. Gallen I (gamma 292 Gly--> Val): evidence for structural alterations causing defective polymerization and fibrinogenolysis. Stucki B; Schmutz P; Schmid L; Haeberli A; Lämmle B; Furlan M Thromb Haemost; 1999 Feb; 81(2):268-74. PubMed ID: 10064005 [TBL] [Abstract][Full Text] [Related]
9. Fibrinogen Šumperk II: dysfibrinogenemia in an individual with two coding mutations. Kotlín R; Suttnar J; Cápová I; Hrachovinová I; Urbánková M; Dyr JE Am J Hematol; 2012 May; 87(5):555-7. PubMed ID: 22407772 [TBL] [Abstract][Full Text] [Related]
10. Fibrinogen Darlinghurst: hypofibrinogenaemia caused by a W253G mutation in the gamma chain in a patient with both bleeding and thrombotic complications. Sheen CR; Low J; Joseph J; Kotlyar E; George PM; Brennan SO Thromb Haemost; 2006 Nov; 96(5):685-7. PubMed ID: 17080227 [No Abstract] [Full Text] [Related]
11. Identification of Two Novel Fibrinogen Bβ Chain Mutations in Two Slovak Families with Quantitative Fibrinogen Disorders. Simurda T; Zolkova J; Snahnicanova Z; Loderer D; Skornova I; Sokol J; Hudecek J; Stasko J; Lasabova Z; Kubisz P Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29286337 [TBL] [Abstract][Full Text] [Related]
12. A case of congenital afibrinogenemia: fibrinogen Hakata, a novel nonsense mutation of the fibrinogen gamma-chain gene. Iida H; Ishii E; Nakahara M; Urata M; Wakiyama M; Kurihara M; Watanabe K; Kai T; Ihara K; Kinoshita S; Hamasaki N Thromb Haemost; 2000 Jul; 84(1):49-53. PubMed ID: 10928469 [TBL] [Abstract][Full Text] [Related]
13. Functional characterisation of plasma fibrin clots in Polish carriers of fibrinogen gammaArg275His mutation (fibrinogen Zabrze). Undas A; Pastuszczak M; Iwaniec T; Kapelak K; Neerman-Arbez M Thromb Haemost; 2010 Aug; 104(2):415-7. PubMed ID: 20508898 [No Abstract] [Full Text] [Related]
14. Familial dysfibrinogenemia and thrombophilia. Report on a study of the SSC Subcommittee on Fibrinogen. Haverkate F; Samama M Thromb Haemost; 1995 Jan; 73(1):151-61. PubMed ID: 7740487 [TBL] [Abstract][Full Text] [Related]
15. Severe bleeding and miscarriages in a hypofibrinogenemic woman heterozygous for the gamma Ala82Gly mutation. Zdziarska J; Undas A; Basa J; Iwaniec T; Skotnicki AB; de Moerloose P; Neerman-Arbez M Blood Coagul Fibrinolysis; 2009 Jul; 20(5):374-6. PubMed ID: 19300242 [TBL] [Abstract][Full Text] [Related]
16. Fibrinogen Tolaga Bay: a novel gammaAla341Val mutation causing hypofibrinogenaemia. Davis RL; Brennan SO Thromb Haemost; 2007 Nov; 98(5):1136-8. PubMed ID: 18000621 [No Abstract] [Full Text] [Related]
17. A C-terminal amino acid substitution in the gamma-chain caused by a novel heterozygous frameshift mutation (Fibrinogen Matsumoto VII) results in hypofibrinogenaemia. Fujihara N; Haneishi A; Yamauchi K; Terasawa F; Ito T; Ishida F; Okumura N Thromb Haemost; 2010 Aug; 104(2):213-23. PubMed ID: 20589319 [TBL] [Abstract][Full Text] [Related]
18. Paradoxical bleeding and thrombosis in a patient with afibrinogenemia and fibrinogen Mumbai mutation. Mukaddam A; Patil R; Jadli A; Chandrakala S; Ghosh K; Shetty S Am J Clin Pathol; 2015 May; 143(5):755-7. PubMed ID: 25873512 [TBL] [Abstract][Full Text] [Related]
19. A novel fibrinogen γ chain frameshift deletion (c.637delT) in a patient with hypodysfibrinogenemia associated with thrombosis. Ivaškevičius V; Thomas A; Biswas A; Ensikat H; Schmitt U; Horneff S; Pavlova A; Poetzsch B; Oldenburg J Hamostaseologie; 2015; 35 Suppl 1():S27-31. PubMed ID: 26540127 [TBL] [Abstract][Full Text] [Related]